Skip to main content
Log in

Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to describe the incidence and contributory risk factors for thromboembolic complications in children with nephrotic syndrome (NS) and thrombosis.

Methods

Among 188 children with the diagnosis of NS (80 girls; mean age: 12.6 ± 5.4 years) followed up in our hospital for the last 5 years, 17 (9.0 %) children (16 boys) identified as having thromboembolic complications. All 17 children with NS and thrombosis were screened for laboratory risk factors for thrombosis. The diagnosis was confirmed by cranial magnetic resonance imaging, doppler ultrasonography, and echocardiography.

Results

Among 17 children with thrombosis, 14 (82.3 %) were found to have focal segmental glomerulosclerosis (FSGS) as underlying pathology by renal biopsy. The mean age of the thrombotic children was 4.5 ± 3.2 years at the diagnosis of NS and that was 7.1 ± 4.9 years at the time of thrombosis. The mean time from NS diagnosis to the first thrombosis development was 2.6 ± 2.3 years. Thrombosis occurred during the first year of NS in 9/17 (52.9 %) children. Most of the children (88.2 %) had venous thrombosis. Among the screened risk factors, high factor VIII level (64.7 %) was the leading factor followed by decreased antithrombin III level (29.4 %). Furthermore, 4 children had central venous catheters and 2 had infection as clinical risk factors for thrombosis.

Conclusion

In this case series, subtype of FSGS, active disease state of NS, central venous catheters, and some inherited and acquired thrombotic risk factors have been identified as contributory factors for the development of thrombosis in children with NS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629–39.

    Article  PubMed  Google Scholar 

  2. Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a midwest pediatric nephrology consortium (MWPNC) study. J Pediatr. 2009;155:105–10.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;7:513–20.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Tizki S, Lasry F, Khalifa HH, Itri M. Primary focal segmental glomerular sclerosis in children: epidemiology and prognosis. Nephrol Ther. 2013;9:433–7.

    Article  PubMed  Google Scholar 

  5. Gokce M, Altan I, Unal S, Kuskonmaz B, Aytac S, Cetin M, et al. Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors. Blood Coagul Fibrinolysis. 2012;23:434–9.

    Article  CAS  PubMed  Google Scholar 

  6. Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE. Reference values in infancy and childhood. Nathan and Oski’s hematology of infancy and childhood. 7th ed. Philadelphia: Saunders, Elsevier; 2009. p. 1771–96.

    Google Scholar 

  7. Gürgey A, Mesci L. The prevalence of factor V Leiden (1691 G→A) mutation in Turkey. Turk J Pediatr. 1997;39:313–5.

    PubMed  Google Scholar 

  8. Gürgey A, Hicsönmez G, Parlak H, Balta G, Celiker A. Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol. 1998;59:179–80.

    Article  PubMed  Google Scholar 

  9. Balta G, Gürgey A. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197–9.

    CAS  PubMed  Google Scholar 

  10. Balta G, Altay C, Gurgey A. PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol. 2002;71:89–93.

    Article  CAS  PubMed  Google Scholar 

  11. Bilginer Y, Ozaltin F, Duzova A, Erdogan I, Aki TF, Demircin M, et al. Right atrial thrombosis complicating renal transplantation in a child. Pediatr Transplant. 2008;12:251–5.

    Article  CAS  PubMed  Google Scholar 

  12. Topaloğlu R, Saatçi U, Bakkaloğlu A, Beşbaş N, Başsoy Y. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial mediterranean fever-related amyloidosis. Turk J Pediatr. 1992;34:15–20.

    PubMed  Google Scholar 

  13. Loscalzo J. Venous thrombosis in the nephrotic syndrome. N Engl J Med. 2013;368:956–8.

    Article  CAS  PubMed  Google Scholar 

  14. Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994;46:287–96.

    Article  CAS  PubMed  Google Scholar 

  15. Abella EM. Hemostatic problems associated with renal disease. Int J Pediatr Hematol Oncol. 1994;1:43–51.

    Google Scholar 

  16. Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J. Thromboembolic complications in children with nephrotic syndrome. Acta Pediatr Scand. 1986;75:804–10.

    Article  CAS  Google Scholar 

  17. Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974—1996). Pediatr Nephrol. 2000;15:74–8.

    Article  CAS  PubMed  Google Scholar 

  18. Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton). 2012;17:338–45.

    Article  CAS  Google Scholar 

  19. Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol. 2008;28:197–202.

    Article  CAS  PubMed  Google Scholar 

  20. Gurgey A, Balta G, Gumruk F, Altay C. Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis. Blood Coagul Fibrinolysis. 2004;15:657–62.

    Article  CAS  PubMed  Google Scholar 

  21. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. 677 →CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey. Arch Dis Child Fetal Neonatal Ed. 1998;78:F235.

    Article  CAS  PubMed  Google Scholar 

  22. Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase677 C-T variants in Turkish children with cerebral infarct. J Child Neurol. 1999;14:749–51.

    Article  CAS  PubMed  Google Scholar 

  23. Balta G, Gürgey A. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197–9.

    CAS  PubMed  Google Scholar 

  24. Boduroğlu K, Alanay Y, Alikaşifoğlu M, Aktaş D, Tunçbilek E. Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. Turk J Pediatr. 2005;47:327–33.

    PubMed  Google Scholar 

  25. Manco-Johnson MJ. How i treat venous thrombosis in children. Blood. 2006;2006(107):21–9.

    Article  Google Scholar 

Download references

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rezan Topaloglu.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tavil, B., Kara, F., Topaloglu, R. et al. Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience. Clin Exp Nephrol 19, 506–513 (2015). https://doi.org/10.1007/s10157-014-1005-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-014-1005-y

Keywords

Navigation